Fibroblast Growth Factor 9 Regulation by MicroRNAs Controls Lung Development and Links DICER1 Loss to the Pathogenesis of Pleuropulmonary Blastoma

PLoS Genetics

Volumn 11, Issue 5, 2015, Pages

  Yin, Yongjun ^a   Castro, Angela M ^a   Hoekstra, Marrit ^b   Yan, Thomas J ^a   Kanakamedala, Ajay C ^a   Dehner, Louis P ^a   Hill, D Ashley ^a   Ornitz, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 9; MICRORNA; MICRORNA 140; MICRORNA 182; MICRORNA 328; UNCLASSIFIED DRUG; BETA CATENIN; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; DICER1 PROTEIN, MOUSE; FGF9 PROTEIN, HUMAN; FGF9 PROTEIN, MOUSE; MIRN140 MICRORNA, HUMAN; MIRN140 MICRORNA, MOUSE; RIBONUCLEASE III;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CONTROLLED STUDY; DICER1 GENE; DISEASE CLASSIFICATION; DISEASE COURSE; EMBRYO; FGF9 GENE; GENE; GENE CONTROL; GENE DOSAGE; GENE INACTIVATION; GENE LOSS; GENE OVEREXPRESSION; GENE TARGETING; GENETIC CONSERVATION; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS EPITHELIUM; LUNG BLASTOMA; LUNG DEVELOPMENT; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PLEUROPULMONARY BLASTOMA; SIGNAL TRANSDUCTION; ANIMAL; DISEASE MODEL; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; LUNG; MALE; MESODERM; METABOLISM; PATHOLOGY; WNT SIGNALING PATHWAY;

MUS;

ANIMALS; BETA CATENIN; DEAD-BOX RNA HELICASES; DISEASE MODELS, ANIMAL; EPITHELIUM; FEMALE; FIBROBLAST GROWTH FACTOR 9; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LUNG; MALE; MESODERM; MICE; MICE, KNOCKOUT; MICRORNAS; PULMONARY BLASTOMA; RIBONUCLEASE III; WNT SIGNALING PATHWAY;

EID: 84930814891     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1005242     Document Type: Article

References (66)

1. Colvin JS, White A, Pratt SJ, Ornitz DM, Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development. 2001;128:2095–106. 11493531
2. White AC, Xu J, Yin Y, Smith C, Schmid G, Ornitz DM, FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains. Development. 2006;133(8):1507–17. Epub 2006/03/17. 16540513
3. Yin Y, White AC, Huh SH, Hilton MJ, Kanazawa H, Long F, et al. An FGF-WNT gene regulatory network controls lung mesenchyme development. Dev Biol. 2008;319(2):426–36. doi: 10.1016/j.ydbio.2008.04.009 18533146
4. Bartel DP, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97. 14744438
5. Vasudevan S, Posttranscriptional upregulation by microRNAs. Wiley Interdiscip Rev RNA. 2012;3(3):311–30. Epub 2011/11/11. doi: 10.1002/wrna.121 22072587
6. Harris KS, Zhang Z, McManus MT, Harfe BD, Sun X, Dicer function is essential for lung epithelium morphogenesis. Proc Natl Acad Sci U S A. 2006;103(7):2208–13. Epub 2006/02/03. 16452165
7. Boman F, Hill DA, Williams GM, Chauvenet A, Fournet JC, Soglio DB, et al. Familial association of pleuropulmonary blastoma with cystic nephroma and other renal tumors: a report from the International Pleuropulmonary Blastoma Registry. J Pediatr. 2006;149(6):850–4. Epub 2006/12/02. 17137906
8. Priest JR, Watterson J, Strong L, Huff V, Woods WG, Byrd RL, et al. Pleuropulmonary blastoma: a marker for familial disease. J Pediatr. 1996;128(2):220–4. Epub 1996/02/01. 8636815
9. Manivel JC, Priest JR, Watterson J, Steiner M, Woods WG, Wick MR, et al. Pleuropulmonary blastoma. The so-called pulmonary blastoma of childhood. Cancer. 1988;62(8):1516–26. Epub 1988/10/15. 3048630
10. Slade I, Bacchelli C, Davies H, Murray A, Abbaszadeh F, Hanks S, et al. DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet. 2011;48(4):273–8. Epub 2011/01/27. doi: 10.1136/jmg.2010.083790 21266384
11. Schultz KA, Pacheco MC, Yang J, Williams GM, Messinger Y, Hill DA, et al. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry. Gynecol Oncol. 2011;122(2):246–50. Epub 2011/04/20. doi: 10.1016/j.ygyno.2011.03.024 21501861
12. Dehner LP, Jarzembowski JA, Hill DA, Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations. Mod Pathol. 2012;25(4):602–14. Epub 2011/12/14. doi: 10.1038/modpathol.2011.185 22157934
13. Doros L, Yang J, Dehner L, Rossi CT, Skiver K, Jarzembowski JA, et al. DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome. Pediatr Blood Cancer. 2012;59(3):558–60. Epub 2011/12/20. doi: 10.1002/pbc.24020 22180160
14. Heravi-Moussavi A, Anglesio MS, Cheng SW, Senz J, Yang W, Prentice L, et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med. 2012;366(3):234–42. Epub 2011/12/23. doi: 10.1056/NEJMoa1102903 22187960
15. Doros L, Schultz KA, Stewart DR, Bauer AJ, Williams G, Rossi CT, et al. DICER1-related disorders. Seattle (WA): University of Washington, Seattle; 1993–2015; 2014. http://www.ncbi.nlm.nih.gov/books/NBK196157/.
16. Hill DA, Jarzembowski JA, Priest JR, Williams G, Schoettler P, Dehner LP, Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol. 2008;32(2):282–95. Epub 2008/01/29. doi: 10.1097/PAS.0b013e3181484165 18223332
17. Messinger YH, Stewart DR, Priest JR, Williams GM, Harris AK, Schultz KA, et al. Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer. 2015;121(2):276–85. doi: 10.1002/cncr.29032 25209242
18. Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science. 2009;325(5943):965. Epub 2009/06/27. doi: 10.1126/science.1174334 19556464
19. Lu J, Qian J, Chen F, Tang X, Li C, Cardoso WV, Differential expression of components of the microRNA machinery during mouse organogenesis. Biochem Biophys Res Commun. 2005;334(2):319–23. Epub 2005/07/23. 16036130
20. Ornitz DM, Yin Y, Signaling networks regulating development of the lower respiratory tract. Cold Spring Harb Perspect Biol. 2012;4(5):1–19.
21. Yin Y, Wang F, Ornitz DM, Mesothelial- and epithelial-derived FGF9 have distinct functions in the regulation of lung development. Development. 2011;138(15):3169–77. doi: 10.1242/dev.065110 21750028
22. del Moral PM, De Langhe SP, Sala FG, Veltmaat JM, Tefft D, Wang K, et al. Differential role of FGF9 on epithelium and mesenchyme in mouse embryonic lung. Dev Biol. 2006;293(1):77–89. Epub 2006/02/24. 16494859
23. Harfe BD, Scherz PJ, Nissim S, Tian H, McMahon AP, Tabin CJ, Evidence for an expansion-based temporal Shh gradient in specifying vertebrate digit identities. Cell. 2004;118(4):517–28. 15315763
24. Cobb BS, Nesterova TB, Thompson E, Hertweck A, O'Connor E, Godwin J, et al. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med. 2005;201(9):1367–73. Epub 2005/05/04. 15867090
25. De Langhe SP, Carraro G, Tefft D, Li C, Xu X, Chai Y, et al. Formation and differentiation of multiple mesenchymal lineages during lung development is regulated by beta-catenin signaling. PLoS One. 2008;3(1):e1516. doi: 10.1371/journal.pone.0001516 18231602
26. Carraro G, El-Hashash A, Guidolin D, Tiozzo C, Turcatel G, Young BM, et al. miR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-Cadherin distribution. Dev Biol. 2009;333(2):238–50. Epub 2009/06/30. doi: 10.1016/j.ydbio.2009.06.020 19559694
27. Dong J, Jiang G, Asmann YW, Tomaszek S, Jen J, Kislinger T, et al. MicroRNA networks in mouse lung organogenesis. PLoS One. 2010;5(5):e10854. Epub 2010/06/04. doi: 10.1371/journal.pone.0010854 20520778
28. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006;9(3):189–98. Epub 2006/03/15. 16530703
29. Sun Y, Fang R, Li C, Li L, Li F, Ye X, et al. Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. Biochem Biophys Res Commun. 2010;396(2):501–7. Epub 2010/04/28. doi: 10.1016/j.bbrc.2010.04.127 20420807
30. Barshack I, Lithwick-Yanai G, Afek A, Rosenblatt K, Tabibian-Keissar H, Zepeniuk M, et al. MicroRNA expression differentiates between primary lung tumors and metastases to the lung. Pathol Res Pract. 2010;206(8):578–84. Epub 2010/04/27. doi: 10.1016/j.prp.2010.03.005 20418022
31. Obad S, dos Santos CO, Petri A, Heidenblad M, Broom O, Ruse C, et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet. 2011;43(4):371–8. Epub 2011/03/23. doi: 10.1038/ng.786 21423181
32. Del Moral PM, Warburton D, Explant culture of mouse embryonic whole lung, isolated epithelium, or mesenchyme under chemically defined conditions as a system to evaluate the molecular mechanism of branching morphogenesis and cellular differentiation. Methods Mol Biol. 2010;633:71–9. Epub 2010/03/06. doi: 10.1007/978-1-59745-019-5_5 20204620
33. Kreda SM, Gynn MC, Fenstermacher DA, Boucher RC, Gabriel SE, Expression and localization of epithelial aquaporins in the adult human lung. Am J Respir Cell Mol Biol. 2001;24(3):224–34. Epub 2001/03/14. 11245621
34. Ramirez MI, Millien G, Hinds A, Cao Y, Seldin DC, Williams MC, T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev Biol. 2003;256(1):61–72. Epub 2003/03/26. 12654292
35. Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, Yokoyama S, et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 2010;24(11):1173–85. Epub 2010/05/15. doi: 10.1101/gad.1915510 20466812
36. McDonald FJ, Western AH, McNeil JD, Thomas BC, Olson DR, Snyder PM, Ubiquitin-protein ligase WWP2 binds to and downregulates the epithelial Na(+) channel. Am J Physiol Renal Physiol. 2002;283(3):F431–6. Epub 2002/08/09. 12167593
37. Yang J, Qin S, Yi C, Ma G, Zhu H, Zhou W, et al. MiR-140 is co-expressed with Wwp2-C transcript and activated by Sox9 to target Sp1 in maintaining the chondrocyte proliferation. FEBS Lett. 2011;585(19):2992–7. Epub 2011/08/30. doi: 10.1016/j.febslet.2011.08.013 21872590
38. Hung IH, Yu K, Lavine KJ, Ornitz DM, FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod. Dev Biol. 2007;307(2):300–13. 17544391
39. Chang DR, Martinez Alanis D, Miller RK, Ji H, Akiyama H, McCrea PD, et al. Lung epithelial branching program antagonizes alveolar differentiation. Proc Natl Acad Sci U S A. 2013;110(45):18042–51. Epub 2013/09/24. doi: 10.1073/pnas.1311760110 24058167
40. Li Q, Yao Y, Eades G, Liu Z, Zhang Y, Zhou Q, Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer. Oncogene. 2014;33(20):2589–600. Epub 2013/06/12. doi: 10.1038/onc.2013.226 23752191
41. Yuan Y, Shen Y, Xue L, Fan H, miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor. PLoS One. 2013;8(9):e73604. Epub 2013/09/17. doi: 10.1371/journal.pone.0073604 24039995
42. Yang H, Fang F, Chang R, Yang L, MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor beta receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology. 2013;58(1):205–17. Epub 2013/02/13. doi: 10.1002/hep.26315 23401231
43. Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene. 2009;28(46):4065–74. Epub 2009/09/08. doi: 10.1038/onc.2009.274 19734943
44. Zhang Y, Eades G, Yao Y, Li Q, Zhou Q, Estrogen receptor alpha signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2. J Biol Chem. 2012;287(49):41514–22. Epub 2012/10/13. doi: 10.1074/jbc.M112.404871 23060440
45. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, et al. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007;67(18):8699–707. Epub 2007/09/19. 17875710
46. Sand M, Skrygan M, Sand D, Georgas D, Hahn SA, Gambichler T, et al. Expression of microRNAs in basal cell carcinoma. Br J Dermatol. 2012;167(4):847–55. Epub 2012/05/01. doi: 10.1111/j.1365-2133.2012.11022.x 22540308
47. Yin Y, Betsuyaku T, Garbow JR, Miao J, Govindan R, Ornitz DM, Rapid induction of lung adenocarcinoma by fibroblast growth factor 9 signaling through FGF receptor 3. Cancer Res. 2013;73(18):5730–41. Epub 2013/07/23. doi: 10.1158/0008-5472.CAN-13-0495 23867472
48. Ohgino K, Soejima K, Yasuda H, Hayashi Y, Hamamoto J, Naoki K, et al. Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer. Lung Cancer. 2014;83(1):90–6. Epub 2013/11/19. doi: 10.1016/j.lungcan.2013.10.016 24239165
49. Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stuhler K, Meyer HE, et al. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol. 2010;20(3):539–50. Epub 2009/09/25. doi: 10.1111/j.1750-3639.2009.00328.x 19775293
50. Wu Z, Sun L, Wang H, Yao J, Jiang C, Xu W, et al. MiR-328 expression is decreased in high-grade gliomas and is associated with worse survival in primary glioblastoma. PLoS One. 2012;7(10):e47270. Epub 2012/10/19. doi: 10.1371/journal.pone.0047270 23077581
51. Xu XT, Xu Q, Tong JL, Zhu MM, Nie F, Chen X, et al. MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer. Br J Cancer. 2012;106(7):1320–30. Epub 2012/03/29. doi: 10.1038/bjc.2012.88 22453125
52. Pan YZ, Morris ME, Yu AM, MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol. 2009;75(6):1374–9. Epub 2009/03/10. doi: 10.1124/mol.108.054163 19270061
53. Miyamoto M, Naruo K, Seko C, Matsumoto S, Kondo T, Kurokawa T, Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol Cell Biol. 1993;13(7):4251–9. Epub 1993/07/01. 8321227
54. Gau BH, Chen TM, Shih YH, Sun HS, FUBP3 interacts with FGF9 3' microsatellite and positively regulates FGF9 translation. Nucleic Acids Res. 2011;39(9):3582–93. Epub 2011/01/22. doi: 10.1093/nar/gkq1295 21252297
55. Sgantzis N, Yiakouvaki A, Remboutsika E, Kontoyiannis DL, HuR controls lung branching morphogenesis and mesenchymal FGF networks. Dev Biol. 2011;354(2):267–79. Epub 2011/04/26. doi: 10.1016/j.ydbio.2011.04.003 21515253
56. Pugh TJ, Yu W, Yang J, Field AL, Ambrogio L, Carter SL, et al. Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences. Oncogene. 2014;33(45):5295–302. Epub 2014/06/10. doi: 10.1038/onc.2014.150 24909177
57. Seki M, Yoshida K, Shiraishi Y, Shimamura T, Sato Y, Nishimura R, et al. Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma. Cancer Res. 2014;74(10):2742–9. Epub 2014/03/29. doi: 10.1158/0008-5472.CAN-13-2470 24675358
58. Soriano A, Jubierre L, Almazan-Moga A, Molist C, Roma J, de Toledo JS, et al. microRNAs as pharmacological targets in cancer. Pharmacol Res. 2013;75:3–14. Epub 2013/03/30. doi: 10.1016/j.phrs.2013.03.006 23537752
59. Wagh PK, Gardner MA, Ma X, Callahan M, Shannon JM, Wert SE, et al. Cell- and developmental stage-specific Dicer1 ablation in the lung epithelium models cystic pleuropulmonary blastoma. J Pathol. 2015;236(1):41–52. Epub 2014/12/17. doi: 10.1002/path.4500 25500911
60. Lin Y, Liu G, Wang F, Generation of an Fgf9 conditional null allele. Genesis. 2006;44(3):150–4. Epub 2006/02/24. 16496342
61. Perl AK, Wert SE, Nagy A, Lobe CG, Whitsett JA, Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc Natl Acad Sci U S A. 2002;99(16):10482–7. 12145322
62. Colvin JS, Feldman B, Nadeau JH, Goldfarb M, Ornitz DM, Genomic organization and embryonic expression of the mouse fibroblast growth factor 9 gene. Dev Dyn. 1999;216(1):72–88. 10474167
63. Kratochwil K, Dull M, Farinas I, Galceran J, Grosschedl R, Lef1 expression is activated by BMP-4 and regulates inductive tissue interactions in tooth and hair development. Genes Dev. 1996;10(11):1382–94. 8647435
64. Xu J, Tian J, Grumelli SM, Haley KJ, Shapiro SD, Stage-specific effects of cAMP signaling during distal lung epithelial development. J Biol Chem. 2006;281(50):38894–904. Epub 2006/10/05. 17018522
65. Naski MC, Colvin JS, Coffin JD, Ornitz DM, Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development. 1998;125(24):4977–88. 9811582
66. Stein CA, Hansen JB, Lai J, Wu S, Voskresenskiy A, Hog A, et al. Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res. 2010;38(1):e3. Epub 2009/10/27. doi: 10.1093/nar/gkp841 19854938